|
Variables
|
|---|
|
Agea
|
year
|
42.4 ± 14.7
|
|
Body mass indexa
|
kg/m2
|
24.2 ± 3.1
|
|
Smoker / non smoker
|
n
|
13 / 41
|
|
HAM-Da
| |
19.3 ± 7.0
|
|
GAFa
| |
32.4 ± 7.6
|
|
Duration of illnessa
|
year
|
6.2 ± 7.9
|
|
No. depressive episodesa
| |
1.7 ± 1.1
|
|
Antidepressant use
|
n (%)
|
39 (72.2)
|
|
TCA
|
n (%)
|
1 (1.8)
|
|
SSRI
|
n (%)
|
27 (50.0)
|
|
SNRI
|
n (%)
|
7 (13.0)
|
|
NaSSA
|
n (%)
|
4 (7.4)
|
|
Imipramine equivalencea
|
mg/day
|
110.7 ± 95.4
|
|
Benzodiazepine use
|
n (%)
|
17 (31.5)
|
|
Severity/course specifier at first medical examinationenzodiazepine use
|
|
Mild
|
n (%)
|
14 (25.9)
|
|
Moderate
|
n (%)
|
29 (53.7)
|
|
Severe
|
n (%)
|
5 (9.2)
|
|
With psychotic features
|
n (%)
|
3 (5.6)
|
|
In partial remission
|
n (%)
|
3 (5.6)
|
- aValues are presented as mean ± standard deviation
- Abbreviations: HAM-D Hamilton Rating Scale for Depression, TCA Tricyclic antidepressants, SSRI Selective serotonin reuptake inhibitors, SNRI Serotonin-norepinephrine reuptake inhibitors, NaSSA Noradrenergic and specific serotonergic sntidepressant
